COMBRETASTATIN A-4;(Z)-2-Methoxy-5-(3,4,5-Trimethoxystyryl)Phenol;(Z)-2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol,3,4,5-Trimethoxy-3hydroxy-4methoxy-(Z)-stilbene,CS-A4;Combrestatin A4( 2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol );CA-4;Combretastatin A4;2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]Phenol;Combrestatin A4;CRC 87-09;2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol;3'-Hydroxy-3,4,4',5-tetramethoxy-cis-stilbene;1-(3,4,5-Trimethoxyphenyl)-2-(3′-hydroxy-4′-methoxyphenyl) ethane 3,4,5-trimethoxy-3′-hydroxy-4′-methoxystilbene;2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol;CA4;(Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)phenol;CS-A4;CoMbretastatin A;(Z)-CombretastatinA4;CA-4, Combretastatin A-4;combretastatin A-4 (CA-4);Combretastatin A4 (CRC 87-09);(Z)-5-(3,4,5-trimethoxystyryl)-2-methoxyphenol